Hospital groups that recently filed a motion to intervene in opposition to drug manufacturer Eli Lilly’s lawsuit against the federal government over 340B contract pharmacy requirements also are trying to intervene in similar suits against the government by manufacturers AstraZeneca, Novo Nordisk, and Sanofi.
The six groups—American Hospital Association (AHA), 340B Health, America’s Essential Hospitals, the Association of American Medical Colleges (AAMC), Children’s Hospital Association (CHA), and ASHP (American Society of Health-System Pharmacists)—on Friday jointly filed a motion to intervene in AstraZeneca’s lawsuit in federal district court in Delaware. On Tuesday, they similarly filed motions in federal court in New Jersey in Sanofi’s and Novo Nordisk’s lawsuits. Lilly’s case is being heard in Indianapolis.
Hospital groups that recently filed a motion to intervene in opposition to drug manufacturer Eli Lilly’s lawsuit against the federal government over 340B contract pharmacy requirements also are trying to intervene in similar suits against the government by manufacturers AstraZeneca, Novo Nordisk, and Sanofi.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
